Veradermics MANE Cash Flow Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|
| —— | —— | —— | -$32.27M— | ||
| —— | —— | —— | $400.5K— | ||
| —— | —— | —— | -$31.08M— | ||
| —— | —— | —— | $19K— | ||
| —— | —— | —— | -$15.75M— | ||
| $0-100% | $211.25K— | $422.5K— | $633.75K— | ||
| —— | —— | —— | $53.78M— | ||
| —— | —— | —— | $6.95M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Veradermics generate?
- Veradermics (MANE) generated -$46.3M in operating cash flow over the trailing twelve months.
- What is Veradermics 's free cash flow?
- After $19.0K of capital expenditures, Veradermics 's free cash flow was -$46.3M over the trailing twelve months.
- Where does Veradermics 's cash flow data come from?
- Every line is extracted from Veradermics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.